Correlation Between GeneFerm Biotechnology and DV Biomed

Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and DV Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and DV Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneFerm Biotechnology Co and DV Biomed Co, you can compare the effects of market volatilities on GeneFerm Biotechnology and DV Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of DV Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and DV Biomed.

Diversification Opportunities for GeneFerm Biotechnology and DV Biomed

0.56

Correlation Coefficient

GeneFerm Biotechnology  DV Biomed

Very weak diversification

The 3 months correlation between GeneFerm and 6539 is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and DV Biomed Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DV Biomed and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with DV Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DV Biomed has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and DV Biomed go up and down completely randomly.

Pair Corralation between GeneFerm Biotechnology and DV Biomed

Assuming the 90 days trading horizon GeneFerm Biotechnology Co is expected to generate 1.38 times more return on investment than DV Biomed. However, GeneFerm Biotechnology is 1.38 times more volatile than DV Biomed Co. It trades about 0.09 of its potential returns per unit of risk. DV Biomed Co is currently generating about 0.06 per unit of risk. If you would invest  4,700  in GeneFerm Biotechnology Co on December 31, 2024 and sell it today you would earn a total of  600.00  from holding GeneFerm Biotechnology Co or generate 12.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

GeneFerm Biotechnology Co  vs.  DV Biomed Co

GeneFerm Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, GeneFerm Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

DV Biomed

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in DV Biomed Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, DV Biomed may actually be approaching a critical reversion point that can send shares even higher in May 2025.

Pair Trading with GeneFerm Biotechnology and DV Biomed

The main advantage of trading using opposite GeneFerm Biotechnology and DV Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, DV Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will offset losses from the drop in DV Biomed's long position.

The idea behind GeneFerm Biotechnology Co and DV Biomed Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.